US Penny Stocks To Watch In January 2025

As the U.S. stock market navigates mixed performances and anticipates key economic data, investors are keeping a close eye on various sectors for potential opportunities. Penny stocks, though often seen as relics of past market eras, continue to offer intriguing possibilities by highlighting smaller or newer companies that may provide both affordability and growth potential. By focusing on those with strong financial health, investors can uncover opportunities that align with their investment goals amidst the current market dynamics.

Top 10 Penny Stocks In The United States

Name	Share Price	Market Cap	Financial Health Rating
BAB (OTCPK:BABB)	$0.81	$5.79M	★★★★★★
Inter & Co (NasdaqGS:INTR)	$4.25	$1.93B	★★★★☆☆
QuantaSing Group (NasdaqGM:QSG)	$3.08	$100.69M	★★★★★★
Kiora Pharmaceuticals (NasdaqCM:KPRX)	$3.7257	$11.81M	★★★★★★
ZTEST Electronics (OTCPK:ZTST.F)	$0.32	$11.77M	★★★★★★
Permianville Royalty Trust (NYSE:PVL)	$1.41	$46.86M	★★★★★★
BTCS (NasdaqCM:BTCS)	$2.49	$44.59M	★★★★★★
Smith Micro Software (NasdaqCM:SMSI)	$1.37	$28.91M	★★★★★☆
CBAK Energy Technology (NasdaqCM:CBAT)	$0.97	$91.74M	★★★★★☆
Safe Bulkers (NYSE:SB)	$3.45	$365.18M	★★★★☆☆

Click here to see the full list of 726 stocks from our US Penny Stocks screener.

Here's a peek at a few of the choices from the screener.

Marqeta (NasdaqGS:MQ)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Marqeta, Inc. operates a cloud-based open application programming interface platform providing card issuing and transaction processing services, with a market cap of approximately $1.94 billion.

Operations: The company generates revenue primarily from services to financial companies, amounting to $490.03 million.

Market Cap: $1.94B

Marqeta, Inc. has recently become profitable, reporting a net income of US$54.41 million for the first nine months of 2024, compared to a significant loss in the previous year. Despite this turnaround, its return on equity remains low at 1.3%, and earnings are expected to decline by an average of 21.6% annually over the next three years. The company is debt-free and has strong short-term asset coverage over its liabilities but faces legal challenges due to alleged misleading statements during a specified period in 2024. Recent partnerships and product launches aim to enhance its BNPL offerings amidst these challenges.

• Navigate through the intricacies of Marqeta with our comprehensive balance sheet health report here.
• Learn about Marqeta's future growth trajectory here.

Nautilus Biotechnology (NasdaqGS:NAUT)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Nautilus Biotechnology, Inc. is a development stage life sciences company focused on creating a platform technology to quantify and unlock the complexity of the proteome, with a market cap of $215.97 million.

Operations: Nautilus Biotechnology, Inc. has not reported any revenue segments.

Market Cap: $215.97M

Nautilus Biotechnology, Inc. operates as a pre-revenue company with no significant revenue streams reported. Despite being debt-free and having adequate short-term asset coverage over its liabilities, the company faces ongoing challenges with increasing losses, reporting a net loss of US$16.45 million in Q3 2024. The management team and board are considered experienced, with an average tenure of 3.6 years. Nautilus has been removed from the NASDAQ Biotechnology Index and is not expected to achieve profitability in the next three years despite forecasts for substantial revenue growth annually at 61.55%.

• Click here to discover the nuances of Nautilus Biotechnology with our detailed analytical financial health report.
• Assess Nautilus Biotechnology's future earnings estimates with our detailed growth reports.

TETRA Technologies (NYSE:TTI)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: TETRA Technologies, Inc. operates as an energy services and solutions company with a market capitalization of approximately $510.11 million.

Operations: The company's revenue is derived from two main segments: Water & Flowback Services, generating $302.75 million, and Completion Fluids & Products, contributing $314.99 million.

Market Cap: $510.11M

TETRA Technologies, Inc. has shown resilience in the energy services sector, with recent advancements like the launch of TETRA Oasis TDS for water treatment and desalination. Despite a challenging third quarter with a net loss of US$3 million and declining profit margins to 1.2%, the company maintains strong short-term asset coverage over its liabilities. Its debt level is high but manageable due to adequate cash flow coverage. Although interest payments are not well covered by earnings, TETRA's strategic focus on innovative solutions could bolster future performance amidst fluctuating market conditions.

• Click here and access our complete financial health analysis report to understand the dynamics of TETRA Technologies.
• Explore TETRA Technologies' analyst forecasts in our growth report.

Seize The Opportunity

• Click this link to deep-dive into the 726 companies within our US Penny Stocks screener.
• Are these companies part of your investment strategy? Use Simply Wall St to consolidate your holdings into a portfolio and gain insights with our comprehensive analysis tools.
• Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe.

Searching for a Fresh Perspective?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Jump on the AI train with fast growing tech companies forging a new era of innovation.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com